These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1819624)

  • 1. Restoration of immune functions after chemotherapy.
    Seminara P; Afeltra A; Codacci Pisanelli M; Aronne T; Franchi F
    J Chemother; 1991 Dec; 3(6):390-1. PubMed ID: 1819624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [50-year-old man with weight loss and splenomegaly].
    Austein T; Schmitt A
    Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
    [No Abstract]   [Full Text] [Related]  

  • 3. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-interferon as induction and maintenance therapy in hairy-cell leukemia: a long-term follow-up analysis.
    Clavio M; Masoudi B; Spriano M; Casciaro S; Gobbi M; Damasio EE
    Haematologica; 1999 May; 84(5):466-8. PubMed ID: 10329930
    [No Abstract]   [Full Text] [Related]  

  • 6. Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature.
    Al-Fiar F; Meharchand J; Curtis J; Lipton JH
    Leuk Res; 1999 Aug; 23(8):719-21. PubMed ID: 10456669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha interferon in the treatment of hairy cell leukemia.
    Tambone Reyes M; Gebbia V; Teresi M; Bonaccorso R; Colucci A; Quartararo L; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1264-5. PubMed ID: 16312859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intermittent interferon alfa in the treatment of hairy cell leukemia].
    Gómez-Almaguer D; Jaime-Pérez JC; Herrera-Garza JL; González-Llano O
    Rev Invest Clin; 1998; 50(4):331-4. PubMed ID: 9830322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.
    Buckstein R; Patel H; Chesney A; Reis M; Imrie K
    Hematology; 2006 Aug; 11(4):267-70. PubMed ID: 17178666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia.
    Benz R; Stussi G; Fehr J
    Br J Haematol; 2010 Feb; 148(4):664-5; author reply 665-6. PubMed ID: 19814738
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical mycobacterial infection in a patient with hairy cell leukemia.
    Trizna Z; Tschen J; Natelson EA
    Cutis; 2001 Mar; 67(3):241-2. PubMed ID: 11270299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?
    Urosevic-Maiwald M; Nobbe S; Kerl K; Benz R
    J Dermatol; 2014 Apr; 41(4):329-33. PubMed ID: 24612373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hairy cell leukemia: therapeutic approaches].
    Paitel JF; Guerci A; Lederlin P
    Rev Med Interne; 1996; 17(5):399-406. PubMed ID: 8763100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible cardiomyopathy in a patient with hairy cell leukaemia.
    Sucak GT; Haznedar R; Yalçin R
    Postgrad Med J; 1998 May; 74(871):313-4. PubMed ID: 9713625
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical relevance of recombinant interferon-alpha 2a antibodies in patients with hairy cell leukemia.
    Steis RG; Longo DL
    J Interferon Res; 1994 Aug; 14(4):207-9. PubMed ID: 7822877
    [No Abstract]   [Full Text] [Related]  

  • 17. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is therapy with cytostatics obsolete in hairy-cell leukemia?
    Franchi F; Seminara P; Codacci-Pisanelli G; Bianco P
    Int J Clin Lab Res; 1992; 22(2):122-3. PubMed ID: 1504306
    [No Abstract]   [Full Text] [Related]  

  • 20. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
    Zaja F; Fanin R; Silvestri F; Russo D; Infanti L; Baccarani M
    Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.